These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25936888)

  • 1. [Metronomic Chemotherapy--A New Path to Treat Advanced Non-small Cell Lung Cancer].
    Zhang S; Liu J; Cheng Y
    Zhongguo Fei Ai Za Zhi; 2015 Apr; 18(4):232-9. PubMed ID: 25936888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future development.
    Cazzaniga ME; Camerini A; Addeo R; Nolè F; Munzone E; Collovà E; Del Conte A; Mencoboni M; Papaldo P; Pasini F; Saracchini S; Bocci G
    Future Oncol; 2016 Feb; 12(3):373-87. PubMed ID: 26584409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metronomic chemotherapy using orally active carboplatin/deoxycholate complex to maintain drug concentration within a tolerable range for effective cancer management.
    Mahmud F; Chung SW; Alam F; Choi JU; Kim SW; Kim IS; Kim SY; Lee DS; Byun Y
    J Control Release; 2017 Mar; 249():42-52. PubMed ID: 28093298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy and Toxicity of Metronomic Oral Vinorelbinen in Advanced Non-small Cell Lung Cancer after Failure to Multiple-lines Treatments].
    Yao S; Gu Y; Zhang Y
    Zhongguo Fei Ai Za Zhi; 2017 Nov; 20(11):737-740. PubMed ID: 29167002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced antitumor and anti-angiogenic effects of metronomic Vinorelbine combined with Endostar on Lewis lung carcinoma.
    Qin RS; Zhang ZH; Zhu NP; Chen F; Guo Q; Hu HW; Fu SZ; Liu SS; Chen Y; Fan J; Han YW
    BMC Cancer; 2018 Oct; 18(1):967. PubMed ID: 30305062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research Group.
    Kontopodis E; Hatzidaki D; Varthalitis I; Kentepozidis N; Giassas S; Pantazopoulos N; Vardakis N; Rovithi M; Georgoulias V; Agelaki S
    J Chemother; 2013 Feb; 25(1):49-55. PubMed ID: 23433445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metronomics chemotherapy: time for computational decision support.
    Barbolosi D; Ciccolini J; Meille C; Elharrar X; Faivre C; Lacarelle B; André N; Barlesi F
    Cancer Chemother Pharmacol; 2014 Sep; 74(3):647-52. PubMed ID: 25082520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metronomic vinorelbine (oral) in combination with sorafenib in advanced non-small cell lung cancer.
    Tan EH; Tan DS; Li WY; Haaland B; Ang MK; Chau NM; Toh CK; Tan IB; Koh TS; Thng CH; Chowbay B; Hui KM; Lim WT; Ng QS
    Lung Cancer; 2015 Jun; 88(3):289-96. PubMed ID: 25896396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial).
    Camerini A; Puccetti C; Donati S; Valsuani C; Petrella MC; Tartarelli G; Puccinelli P; Amoroso D
    BMC Cancer; 2015 May; 15():359. PubMed ID: 25943747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of RRM1 in the Treatment and Prognosis of Advanced Non-small Cell Lung Cancer].
    Tian J; Han S
    Zhongguo Fei Ai Za Zhi; 2015 Jun; 18(6):381-6. PubMed ID: 26104896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study of docetaxel and trofosfamide as second-line 'metronomic' chemotherapy in the treatment of metastatic non-small cell lung cancer (NSCLC).
    Görn M; Habermann CR; Anige M; Thöm I; Schuch G; Andritzky B; Brandl S; Burkholder I; Edler L; Hossfeld DK; Bokemeyer C; Laack E
    Onkologie; 2008 Apr; 31(4):185-9. PubMed ID: 18418020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic antitumor effect of combining metronomic chemotherapy with adoptive cell immunotherapy in nude mice.
    Shi S; Tao L; Song H; Chen L; Huang G
    APMIS; 2014 May; 122(5):380-91. PubMed ID: 24628659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metronomic chemotherapy and immunotherapy in cancer treatment.
    Chen YL; Chang MC; Cheng WF
    Cancer Lett; 2017 Aug; 400():282-292. PubMed ID: 28189534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced treatment of lung cancer by metronomic therapy with oral pemetrexed.
    Park K
    J Control Release; 2018 Aug; 284():250-251. PubMed ID: 30097256
    [No Abstract]   [Full Text] [Related]  

  • 15. Metronomic chemotherapy for advanced breast cancer patients.
    Cazzaniga ME; Dionisio MR; Riva F
    Cancer Lett; 2017 Aug; 400():252-258. PubMed ID: 28017894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metronomic therapy in advanced breast cancer and NSCLC: vinorelbine as a paradigm of recent progress.
    Xu B; Sun T; Wang S; Lin Y
    Expert Rev Anticancer Ther; 2021 Jan; 21(1):71-79. PubMed ID: 33054438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP-binding cassette transporters in tumor endothelial cells and resistance to metronomic chemotherapy.
    Hida K; Kikuchi H; Maishi N; Hida Y
    Cancer Lett; 2017 Aug; 400():305-310. PubMed ID: 28216371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of First-line Chemotherapy with Metronomic Single-agent Oral Vinorelbine in Elderly Patients with NSCLC.
    Mencoboni M; Filiberti RA; Taveggia P; Del Corso L; Del Conte A; Covesnon MG; Puccetti C; Donati S; Auriati L; Amoroso D; Camerini A
    Anticancer Res; 2017 Jun; 37(6):3189-3194. PubMed ID: 28551663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metronomic chemotherapy from rationale to clinical studies: a dream or reality?
    Gnoni A; Silvestris N; Licchetta A; Santini D; Scartozzi M; Ria R; Pisconti S; Petrelli F; Vacca A; Lorusso V
    Crit Rev Oncol Hematol; 2015 Jul; 95(1):46-61. PubMed ID: 25656744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Metronomic Vinorelbine in Advanced Non-small Cell Lung Cancer Patients Unfit for Chemotherapy.
    Banna GL; Camerini A; Bronte G; Anile G; Addeo A; Rundo F; Zanghì G; Lal R; Libra M
    Anticancer Res; 2018 Jun; 38(6):3689-3697. PubMed ID: 29848729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.